European shares closed at a new peak on Tuesday, powered by gains in the healthcare sector, after heavyweight Novo Nordisk clinched U.S. approval of its weight-loss pill. The pan-European STOXX 600 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback